SUMO-2/3 conjugates accumulating under heat shock or MG132 treatment result largely from new protein synthesis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 4, 2012, Pages 911-919

  Častorálová, Markéta ^a   Březinová, Dagmar ^a   Švéda, Martin ^a   Lipov, Jan ^a   Ruml, Tomáš ^a   Knejzlík, Zdeněk ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

Author keywords

17 AAG; Heat shock; MG132; Protein synthesis; SUMO; SUMOylation

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CELL PROTEIN; PROTEASOME; PUROMYCIN; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN;

ARTICLE; CELL STRAIN HEK293; CONJUGATION; ENZYME INHIBITION; HEAT SHOCK; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SUMOYLATION;

BENZOQUINONES; CYCLOHEXIMIDE; HEAT-SHOCK RESPONSE; HEK293 CELLS; HELA CELLS; HUMANS; LACTAMS, MACROCYCLIC; LEUPEPTINS; MODELS, BIOLOGICAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; PUROMYCIN; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; UBIQUITINS;

EID: 84857410438     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.01.010     Document Type: Article

References (46)

1. Tatham M.H., Kim S., Yu B., Jaffray E., Song J., Zheng J., Rodriguez M.S., Hay R.T., Chen Y. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation. Biochemistry 2003, 42:9959-9969.
2. Knipscheer P., van Dijk W.J., Olsen J.V., Mann M., Sixma T.K. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO J. 2007, 26:2797-2807.
3. Azuma Y., Tan S.H., Cavenagh M.M., Ainsztein A.M., Saitoh H., Dasso M. Expression and regulation of the mammalian SUMO-1 E1 enzyme. FASEB J. 2001, 15:1825-1827.
4. Moutty M.C., Sakin V., Melchior F. Importin alpha}/{beta mediates nuclear import of individual SUMO E1 subunits and of the holo-enzyme. Mol. Biol. Cell 2011, 22:652-656.
5. Tang Z., Hecker C.M., Scheschonka A., Betz H. Protein interactions in the sumoylation cascade: lessons from X-ray structures. FEBS J. 2008, 275:3003-3015.
6. Cooper H.J., Tatham M.H., Jaffray E., Heath J.K., Lam T.T., Marshall A.G., Hay R.T. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction. Anal. Chem. 2005, 77:6310-6319.
7. Hsiao H.H., Meulmeester E., Frank B.T., Melchior F., Urlaub H. "ChopNSpice," a mass spectrometric approach that allows identification of endogenous small ubiquitin-like modifier-conjugated peptides. Mol. Cell Proteomics 2009, 8:2664-2675.
8. Chung T.L., Hsiao H.H., Yeh Y.Y., Shia H.L., Chen Y.L., Liang P.H., Wang A.H., Khoo K.H., Shoei-Lung L.S. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides. J. Biol. Chem. 2004, 279:39653-39662.
9. Blomster H.A., Hietakangas V., Wu J., Kouvonen P., Hautaniemi S., Sistonen L. Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites. Mol. Cell Proteomics 2009, 8:1382-1390.
10. Pichler A., Gast A., Seeler J.S., Dejean A., Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 2002, 108:109-120.
11. Tatham M.H., Kim S., Jaffray E., Song J., Chen Y., Hay R.T. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nat. Struct. Mol. Biol. 2005, 12:67-74.
12. Kagey M.H., Melhuish T.A., Wotton D. The polycomb protein Pc2 is a SUMO E3. Cell 2003, 113:127-137.
13. Wotton D., Merrill J.C. Pc2 and SUMOylation. Biochem. Soc. Trans. 2007, 35:1401-1404.
14. Hammer E., Heilbronn R., Weger S. The E3 ligase Topors induces the accumulation of polysumoylated forms of DNA topoisomerase I in vitro and in vivo. FEBS Lett. 2007, 581:5418-5424.
15. Kotaja N., Karvonen U., Janne O.A., Palvimo J.J. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 2002, 22:5222-5234.
16. Palvimo J.J. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem. Soc. Trans. 2007, 35:1405-1408.
17. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8:947-956.
18. Kim J.H., Baek S.H. Emerging roles of desumoylating enzymes. Biochim. Biophys. Acta 2009, 1792:155-162.
19. Vertegaal A.C., Andersen J.S., Ogg S.C., Hay R.T., Mann M., Lamond A.I. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell Proteomics 2006, 5:2298-2310.
20. Ayaydin F., Dasso M. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol. Biol. Cell 2004, 15:5208-5218.
21. Evdokimov E., Sharma P., Lockett S.J., Lualdi M., Kuehn M.R. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3. J. Cell Sci. 2008, 121:4106-4113.
22. Tatham M.H., Jaffray E., Vaughan O.A., Desterro J.M., Botting C.H., Naismith J.H., Hay R.T. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 2001, 276:35368-35374.
23. Matic I., van H.M., Schimmel J., Macek B., Ogg S.C., Tatham M.H., Hay R.T., Lamond A.I., Mann M., Vertegaal A.C. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol. Cell Proteomics 2008, 7:132-144.
24. Saitoh H., Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 2000, 275:6252-6258.
25. Golebiowski F., Matic I., Tatham M.H., Cole C., Yin Y., Nakamura A., Cox J., Barton G.J., Mann M., Hay R.T. System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2009, 2:ra24.
26. Schimmel J., Larsen K.M., Matic I., van H.M., Cox J., Mann M., Andersen J.S., Vertegaal A.C. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol. Cell Proteomics 2008, 7:2107-2122.
27. Uzunova K., Gottsche K., Miteva M., Weisshaar S.R., Glanemann C., Schnellhardt M., Niessen M., Scheel H., Hofmann K., Johnson E.S., Praefcke G.J., Dohmen R.J. Ubiquitin-dependent proteolytic control of SUMO conjugates. J. Biol. Chem. 2007, 282:34167-34175.
28. Sun H., Leverson J.D., Hunter T. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J. 2007, 26:4102-4112.
29. Tatham M.H., Geoffroy M.C., Shen L., Plechanovova A., Hattersley N., Jaffray E.G., Palvimo J.J., Hay R.T. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 2008, 10:538-546.
30. Prudden J., Pebernard S., Raffa G., Slavin D.A., Perry J.J., Tainer J.A., McGowan C.H., Boddy M.N. SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 2007, 26:4089-4101.
31. Taipale M., Jarosz D.F., Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat. Rev. Mol. Cell Biol. 2010, 11:515-528.
32. Hernández M.P., Sullivan W.P., Toft D.O. The assembly and intermolecular properties of the hsp70-Hop-hsp90 molecular chaperone complex. J. Biol. Chem. 2002, 277:38294-38304.
33. Azzam M.E., Algranati I.D. Mechanism of puromycin action: fate of ribosomes after release of nascent protein chains from polysomes. Proc. Natl. Acad. Sci. U. S. A. 1973, 70:3866-3869.
34. Baliga B.S., Pronczuk A.W., Munro H.N. Mechanism of cycloheximide inhibition of protein synthesis in a cell-free system prepared from rat liver. J. Biol. Chem. 1969, 244:4480-4489.
35. McKeehan W., Hardesty B. The mechanism of cycloheximide inhibition of protein synthesis in rabbit reticulocytes. Biochem. Biophys. Res. Commun. 1969, 36:625-630.
36. McIlhinney A., Hogan B.L. Rapid degradation of puromycyl peptides in hepatoma cells and reticulocytes. FEBS Lett. 1974, 40:297-301.
37. Wharton S.A., Hipkiss A.R. Abnormal proteins of shortened length are preferentially degraded in the cytosol of cultured MRC5 fibroblasts. FEBS Lett. 1984, 168:134-138.
38. Whitesell L., Mimnaugh E.G., De Costa B., Myers C.E., Neckers L.M. Inhibition of heat shock protein HSP90-pp 60vsrc heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8324-8328.
39. Hadden M.K., Lubbers D.J., Blagg B.S. Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site. Curr. Top. Med. Chem. 2006, 6:1173-1182.
40. Zhang X.W., Yan X.J., Zhou Z.R., Yang F.F., Wu Z.Y., Sun H.B., Liang W.X., Song A.X., Lallemand-Breitenbach V., Jeanne M., Zhang Q.Y., Yang H.Y., Huang Q.H., Zhou G.B., Tong J.H., Zhang Y., Wu J.H., Hu H.Y., de T.H., Chen S.J., Chen Z. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 2010, 328:240-243.
41. Wang Z., Prelich G. Quality control of a transcriptional regulator by SUMO-targeted degradation. Mol. Cell. Biol. 2009, 29:1694-1706.
42. Chuang S.M., Chen L., Lambertson D., Anand M., Kinzy T.G., Madura K. Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol. Cell. Biol. 2005, 25:403-413.
43. Chuang S.M., Madura K. Saccharomyces cerevisiae Ub-conjugating enzyme Ubc4 binds the proteasome in the presence of translationally damaged proteins. Genetics 2005, 171:1477-1484.
44. Deplazes A., Mockli N., Luke B., Auerbach D., Peter M. Yeast Uri1p promotes translation initiation and may provide a link to cotranslational quality control. EMBO J. 2009, 28:1429-1441.
45. Turner G.C., Varshavsky A. Detecting and measuring cotranslational protein degradation in vivo. Science 2000, 289:2117-2120.
46. Tatham M.H., Matic I., Mann M., Hay R.T. Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci. Signal. 2011, 4:rs4.